Trial Profile
A Phase 2, Randomized, Double-blind, Placebo-controlled, Study to Evaluate Multiple Doses of AK001 in Patients With Moderate to Severe Nasal Polyposis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Sep 2022
Price :
$35
*
At a glance
- Drugs AK 001 (Primary) ; Corticosteroids
- Indications Nasal polyps
- Focus Therapeutic Use
- Sponsors Allakos
- 30 Jul 2020 This study has been Discontinued in United Kingdom as per European Clinical Trials Database.
- 07 Mar 2018 Status changed from active, no longer recruiting to completed.
- 23 Jan 2018 The study has been completed in Belgium.